Application of (2-chloro-5-iodophenyl)(4-fluorophenyl)methanone_Kain Industrial Additive

Background and overview[1][2] (2-Chloro-5-iodophenyl)(4-fluorophenyl)methanone is an intermediate in the synthesis of empagliflozin. Empagliflozin is a type 2 sodium-glucose cotransporter inhibitor jointly developed by Boehringer Ingelheim and Eli Lilly and Company. SGLT-2 inhibitor is a new type of hypoglycemic drug. It mainly inhibits SGLT-2 expressed in the kidney, reduces renal glucose reabsorption, increases the excretion of…